Thrombolysis for acute myocardial infarction: does a greater incidence of reperfusion justify preferential use of an agent?
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy*; D013300:Streptokinase / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase